Overview
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Status:
Recruiting
Recruiting
Trial end date:
2025-04-30
2025-04-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travelPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Vanda Pharmaceuticals
Criteria
Inclusion Criteria:- History of Motion Sickness
- Age 18-75
Exclusion Criteria:
- Nausea-inducing disorder other than motion sickness
- BMI > 40
- History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists